The therapy of acute myelogenous leukemia, a major challenge of onco-hematology
Boiron, M.
Pathologie-Biologie 34(3): 153-156
1986
ISSN/ISBN: 0369-8114 PMID: 3517783 Document Number: 283816
Document emailed within 1 workday
Related Documents
Gale, R.P.; Foon, K.A. 1987: Therapy of acute myelogenous leukemia Seminars in Hematology 24(1): 40-54Bassan, R.; Barbui, T. 1995: Remission induction therapy for adults with acute myelogenous leukemia: towards the ICE age? Haematologica 80(1): 82-90
Ho, A.D.; Lipp, T.; Ehninger, G.; Meyer, P.; Freund, M.; Hunstein, W. 1986: Combination therapy with mitoxantrone and etoposide in refractory acute myelogenous leukemia Cancer Treatment Reports 70(8): 1025-1027
Hamaoka, R.; Jozaki, K.; Amano, T.; Itoh, H.; Imai, Y.; Nishikawa, M.; Kurokawa, M.; Yonezawa, T.; Chinen, Y. 1995: Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(6): 819-822
Sievers, E.L.; Lange, B.J.; Sondel, P.M.; Krailo, M.D.; Gan, J.; Tjoa, T.; Liu-Mares, W.; Feig, S.A. 2000: Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia Cancer Journal from Scientific American 6(Suppl): S39-S44
Pelicci, P.G.; Grignani, F. 1991: Molecular biology in onco-hematology Haematologica 76(Suppl 3): 11-18
Rowe, J.M.; Andersen, J.W.; Cassileth, P.A.; Oken, M.M.; Bennett, J.M.; Wiernik, P.H. 1992: Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience Leukemia 6(Suppl 4): 75-77
Anderlini, P.; Ghaddar, H.M.; Smith, T.L.; Pierce, S.; Kantarjian, H.M.; O'Brien, S.; Keating, M.J.; Freireich, E.J.; Estey, E.H. 1996: Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first Leukemia 10(6): 964-969
Lepage, E. 1989: Metaanalysis: methodology, biostatistic rules, application in onco-hematology Nouvelle Revue Francaise d'Hematologie 31(2): 89-91
Bernasconi, C. 1990: Clinical use of alpha-interferon in onco-hematology: conclusions and prospects Haematologica 75(Suppl 4): 82-84
Alsabti, E.A.; Taleb, A.M.; Raji, H.M.; Kalil, O.Z.; Saleh, K.A. 1979: Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia Japanese Journal of Experimental Medicine 49(3): 157-168
Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596
Dhingra, K.; Talpaz, M.; Kantarjian, H.; Ku, S.; Rothberg, J.; Gutterman, J.U.; Kurzrock, R. 1991: Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression Leukemia 5(3): 191-195
Shumak, K.H.; Baker, M.A.; Taub, R.N.; Coleman, M.S. 1980: Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 40(11): 4048-4052
Anderson, J.K.; Moore, J.O.; Metzgar, R.S. 1979: Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 39(12): 4810-4815
Dunphy, C.H.; Petruska, P.J.; Martin, T.W. 1993: Demonstration of coexistent B-cell lymphoma and therapy-related acute myelogenous leukemia in lymph nodes by flow cytometry and immunohistochemistry. Case report and review of the literature Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 6(4): 500-504
Watanabe, R.; Murata, M.; Takayama, N.; Tokuhira, M.; Kizaki, M.; Okamoto, S.; Kawai, Y.; Watanabe, K.; Murakami, H.; Kikuchi, M.; Nakamura, S.; Ikeda, Y. 1997: Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS) Thrombosis and Haemostasis 77(4): 641-645
Estey, E.H. 2002: Treatment of acute myelogenous leukemia Oncology 16(3): 343-352; 355-356; Discussion 357 362 365-366
Mittal, R.R.; Kullar, J.; Sethi, P.S. 2000: Skin changes in acute myelogenous leukemia Indian Journal of Dermatology Venereology and Leprology 66(5): 266-267
Meisenberg, B. 1995: Treatment of acute myelogenous leukemia New England Journal of Medicine 332(25): 1718; Author Reply 1718-1719